Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare type of leukemia in children, Although BPDCN is a chemo-sensitive tumor, the relapse rate is very high. Tagraxofusp, which is a CD123-directed cytotoxin has been used as a targeted therapy and has shown promising results in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Abla, Dima, Abboud, Miguel R., Noun, Dolly, Tarek, Nidale, Pemmaraju, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027275/
https://www.ncbi.nlm.nih.gov/pubmed/35462725
http://dx.doi.org/10.1016/j.lrr.2022.100313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027275/
https://www.ncbi.nlm.nih.gov/pubmed/35462725
http://dx.doi.org/10.1016/j.lrr.2022.100313

Ejemplares similares